<div class="_item1_gldt3_1" id="overview">
 <h2 class="_title_gldt3_1">
  <span>
   Overview
  </span>
 </h2>
 <!-- -->
 <div class="_item2_gldt3_15" id="basic">
  <h3 class="_title_gldt3_1">
   <span>
    Basic Info
   </span>
  </h3>
  <div class="_content_gldt3_7">
   <!--[-->
   <div class="ant-descriptions ant-descriptions-middle _middle_l74zf_24 _horizontal_l74zf_18 _drugDetailDirection_19rjs_1">
    <!-- -->
    <div class="ant-descriptions-view">
     <table>
      <tbody>
       <!--[-->
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--drugType">
            Drug Type
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--drugType">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               Hormone
               <!--]-->
               <!-- -->
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--synonyms">
            Synonyms
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--synonyms">
            <!--[-->
            <span>
             <!--[-->
             -
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--target">
            Target
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--target">
            <!--[-->
            <span>
             <!--[-->
             -
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--action">
            Action
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--action">
            <!--[-->
            <span>
             <!--[-->
             -
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--mechanism">
            Mechanism
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--mechanism">
            <!--[-->
            <span>
             <!--[-->
             -
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--therapeutic">
            Therapeutic Areas
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--therapeutic">
            <!--[-->
            <span>
             <!--[-->
             -
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--activeDisease">
            Active Indication
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--activeDisease">
            <!--[-->
            <span>
             <!--[-->
             -
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--inActiveDisease">
            Inactive Indication
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--inActiveDisease">
            <!--[-->
            <span>
             <!--[-->
             -
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <!--]-->
      </tbody>
     </table>
    </div>
   </div>
   <div class="ant-descriptions ant-descriptions-middle _middle_l74zf_24 _horizontal_l74zf_18 _drugDetailDirection_19rjs_1">
    <!-- -->
    <div class="ant-descriptions-view">
     <table>
      <tbody>
       <!--[-->
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--originOrg">
            Originator Organization
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--originOrg">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                <!--[-->
                <span class="mr-1 h-5 w-5 flex-shrink-0">
                 <!--[-->
                 <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square ant-avatar-image" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                  <img alt="Shire Plc" src="https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod-us/COMPANY/MASTER/LOGO/a586/caf2/b9c5/11e0/df56/bc90/85b1/43c4/1bee424ec35cff8a_48w.webp"/>
                 </span>
                 <!--]-->
                </span>
                <a class="flex-1 truncate text-black" href="/organization/a586caf2b9c511e0df56bc9085b143c4" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Shire Plc
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <!--]-->
               <!-- -->
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--activeOrg">
            Active Organization
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--activeOrg">
            <!--[-->
            <span>
             <!--[-->
             -
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--inActiveOrg">
            Inactive Organization
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--inActiveOrg">
            <!--[-->
            <span>
             <!--[-->
             <span style="--bdf8c0bc:14px;">
              <!--[-->
              <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
               <!--[-->
               <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                <!--[-->
                <span class="mr-1 h-5 w-5 flex-shrink-0">
                 <!--[-->
                 <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square ant-avatar-image" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                  <img alt="Shire Plc" src="https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod-us/COMPANY/MASTER/LOGO/a586/caf2/b9c5/11e0/df56/bc90/85b1/43c4/1bee424ec35cff8a_48w.webp"/>
                 </span>
                 <!--]-->
                </span>
                <a class="flex-1 truncate text-black" href="/organization/a586caf2b9c511e0df56bc9085b143c4" rel="noopener" target="_blank">
                 <!--[-->
                 <!--[-->
                 Shire Plc
                 <!--]-->
                 <!--]-->
                </a>
                <!-- -->
                <!-- -->
                <!--]-->
               </span>
               <!--]-->
               <!-- -->
              </div>
              <!--]-->
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--globalPhase">
            Drug Highest Phase
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--globalPhase">
            <!--[-->
            <span>
             <!--[-->
             <span class="_tag_5lm5p_1 _primary_5lm5p_10 _small_5lm5p_31 _plain_5lm5p_10" style="background:;color:;">
              <!--[-->
              <span class="">
               Pending
              </span>
              <!--]-->
             </span>
             <span class="ml-1 text-grey-1100">
              <span class="">
               Phase 2
              </span>
             </span>
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--approvalDate">
            First Approval Date
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--approvalDate">
            <!--[-->
            <span>
             <!--[-->
             -
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <tr class="ant-descriptions-row">
        <!--[-->
        <td class="ant-descriptions-item" colspan="1" style="">
         <div class="ant-descriptions-item-container">
          <span class="ant-descriptions-item-label" style="width:190px;">
           <!--[-->
           <span class="_label_l74zf_1" data-testid="descriptions-item__label--regulation">
            Regulation
           </span>
           <!--]-->
          </span>
          <span class="ant-descriptions-item-content" style="max-width:100%;">
           <!--[-->
           <span class="_content_l74zf_6" data-testid="descriptions-item__value--regulation">
            <!--[-->
            <span>
             <!--[-->
             -
             <!--]-->
            </span>
            <!--]-->
           </span>
           <!--]-->
          </span>
         </div>
        </td>
        <!--]-->
       </tr>
       <!--]-->
      </tbody>
     </table>
    </div>
   </div>
   <div class="inline-flex max-w-full mt-4 w-full">
    <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30 _tipsBorder_b7pjb_9" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
     <!--[-->
     <!--]-->
     <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
      <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
      </path>
     </svg>
     <!--[-->
     <span class="_text_b7pjb_17">
      Login to view timeline
     </span>
     <!--]-->
    </div>
   </div>
   <!--]-->
  </div>
 </div>
 <div class="_item2_gldt3_15" id="related">
  <h3 class="_title_gldt3_1">
   <span>
    Related
   </span>
  </h3>
  <div class="_content_gldt3_7">
   <!--[-->
   <div>
    <div class="mb-4 break-all text-sm text-black">
     <div class="inline-flex max-w-full">
      <!--[-->
      <span class="cursor-pointer font-semibold text-seo-blue-500 underline" data-testid="related-clinical-count">
       2
      </span>
      <!--]-->
     </div>
     <span>
      Clinical Trials associated with rhIGF-1/rhIGFBP-3(Takeda)
     </span>
    </div>
    <!--[-->
    <div class="_container_8x5ka_1 _clinicalCard_1rpuv_1" data-testid="clinical-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-wrap items-center justify-start">
        <div class="inline-flex max-w-full">
         <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
          <!--[-->
          <!--]-->
          <!-- -->
          <!--[-->
          <!--[-->
          <span class="text-green-500" data-testid="clinical-document-card__register-number">
           NCT00351221
          </span>
          <!--]-->
          <!--]-->
         </div>
        </div>
        <span class="mx-1 text-grey-450">
         /
        </span>
        <span class="_tag_5lm5p_1 _default_5lm5p_20 _mini_5lm5p_55" data-testid="clinical-study-status" style="background:#FCEDEF;color:#D11A32;">
         <!--[-->
         <span class="">
          Terminated
         </span>
         <!--]-->
        </span>
        <span class="_tag_5lm5p_1 _primary_5lm5p_10 _mini_5lm5p_55 _plain_5lm5p_10 ml-1" data-testid="clinical-document-card__phase" style="background:;color:;">
         <!--[-->
         <span class="">
          Phase 2
         </span>
         <!--]-->
        </span>
        <!-- -->
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_1rpuv_1" data-testid="clinical-document-card__title">
              A Phase 2, Open-Label, Multicenter, Clinical Trial to Evaluate the Pharmacokinetics, Safety and Efficacy of Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 in Children With Growth Failure Due to Noonan Syndrome
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <!-- -->
         <div>
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 hidden md:block" style="--374e759f:60px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <div>
             The trial will investigate the treatment of growth failure in children with Noonan syndrome. Abnormalities in the growth hormone (GH) - insulin-like growth factor-I (IGF-I) axis resulting in low IGF-I levels have been suggested as a possible cause of short stature seen in Noonan syndrome children. Administration of our investigational product is intended to bypass the abnormalities in the GH-IGF axis, and hopefully improve body growth.
            </div>
            <!--]-->
           </div>
           <!-- -->
          </div>
          <!-- -->
          <div class="ant-descriptions ant-descriptions-small _small_l74zf_21 _horizontal_l74zf_18 mt-2 hidden md:block">
           <!-- -->
           <div class="ant-descriptions-view">
            <table>
             <tbody>
              <!--[-->
              <tr class="ant-descriptions-row">
               <!--[-->
               <td class="ant-descriptions-item" colspan="1" style="">
                <div class="ant-descriptions-item-container">
                 <span class="ant-descriptions-item-label" style="width:auto;">
                  <!--[-->
                  <span class="_label_l74zf_1" data-testid="descriptions-item__label--startDate">
                   Start Date
                  </span>
                  <!--]-->
                 </span>
                 <span class="ant-descriptions-item-content" style="max-width:100%;">
                  <!--[-->
                  <span class="_content_l74zf_6" data-testid="descriptions-item__value--startDate">
                   <!--[-->
                   <span class="text-grey-1100" data-testid="clinical-document-card__start-date">
                    -
                   </span>
                   <!--]-->
                  </span>
                  <!--]-->
                 </span>
                </div>
               </td>
               <!--]-->
              </tr>
              <tr class="ant-descriptions-row">
               <!--[-->
               <td class="ant-descriptions-item" colspan="1" style="">
                <div class="ant-descriptions-item-container">
                 <span class="ant-descriptions-item-label" style="width:auto;">
                  <!--[-->
                  <span class="_label_l74zf_1" data-testid="descriptions-item__label--sponsor">
                   Sponsor / Collaborator
                  </span>
                  <!--]-->
                 </span>
                 <span class="ant-descriptions-item-content" style="max-width:100%;">
                  <!--[-->
                  <span class="_content_l74zf_6" data-testid="descriptions-item__value--sponsor">
                   <!--[-->
                   <span style="--bdf8c0bc:14px;">
                    <!--[-->
                    <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
                     <!--[-->
                     <!--[-->
                     <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                      <!--[-->
                      <span class="mr-1 h-5 w-5 flex-shrink-0">
                       <!--[-->
                       <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square ant-avatar-image" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                        <img alt="Insmed, Inc." src="https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod-us/COMPANY/MASTER/LOGO/0dd9/8203/4b08/7605/09ff/2745/2095/28bd/8868e39d58109ac4_48w.webp"/>
                       </span>
                       <!--]-->
                      </span>
                      <a class="flex-1 truncate text-black" href="/organization/0dd982034b08760509ff2745209528bd" rel="noopener" target="_blank">
                       <!--[-->
                       <!--[-->
                       Insmed, Inc.
                       <!--]-->
                       <!--]-->
                      </a>
                      <!-- -->
                      <!-- -->
                      <!--]-->
                     </span>
                     <!--]-->
                     <!--]-->
                     <!-- -->
                    </div>
                    <!--]-->
                   </span>
                   <!--]-->
                  </span>
                  <!--]-->
                 </span>
                </div>
               </td>
               <!--]-->
              </tr>
              <!--]-->
             </tbody>
            </table>
           </div>
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <div class="_container_8x5ka_1 _clinicalCard_1rpuv_1 mt-3" data-testid="clinical-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-wrap items-center justify-start">
        <div class="inline-flex max-w-full">
         <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
          <!--[-->
          <!--]-->
          <!-- -->
          <!--[-->
          <!--[-->
          <span class="text-green-500" data-testid="clinical-document-card__register-number">
           NCT02386839
          </span>
          <!--]-->
          <!--]-->
         </div>
        </div>
        <span class="mx-1 text-grey-450">
         /
        </span>
        <span class="_tag_5lm5p_1 _default_5lm5p_20 _mini_5lm5p_55" data-testid="clinical-study-status" style="background:#E3F1DE;color:#1C6606;">
         <!--[-->
         <span class="">
          Completed
         </span>
         <!--]-->
        </span>
        <span class="_tag_5lm5p_1 _primary_5lm5p_10 _mini_5lm5p_55 _plain_5lm5p_10 ml-1" data-testid="clinical-document-card__phase" style="background:;color:;">
         <!--[-->
         <span class="">
          Phase 2
         </span>
         <!--]-->
        </span>
        <!-- -->
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_1rpuv_1" data-testid="clinical-document-card__title">
              Long-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated With rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal Care
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <!-- -->
         <div>
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 hidden md:block" style="--374e759f:60px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <div>
             The main purpose of this study is to evaluate the long-term efficacy and safety outcomes following short-term exposure to rhIGF-1/rhIGFBP-3 versus standard neonatal care in Study ROPP-2008-01 (NCT01096784).
            </div>
            <!--]-->
           </div>
           <!-- -->
          </div>
          <!-- -->
          <div class="ant-descriptions ant-descriptions-small _small_l74zf_21 _horizontal_l74zf_18 mt-2 hidden md:block">
           <!-- -->
           <div class="ant-descriptions-view">
            <table>
             <tbody>
              <!--[-->
              <tr class="ant-descriptions-row">
               <!--[-->
               <td class="ant-descriptions-item" colspan="1" style="">
                <div class="ant-descriptions-item-container">
                 <span class="ant-descriptions-item-label" style="width:auto;">
                  <!--[-->
                  <span class="_label_l74zf_1" data-testid="descriptions-item__label--startDate">
                   Start Date
                  </span>
                  <!--]-->
                 </span>
                 <span class="ant-descriptions-item-content" style="max-width:100%;">
                  <!--[-->
                  <span class="_content_l74zf_6" data-testid="descriptions-item__value--startDate">
                   <!--[-->
                   <span class="text-grey-1100" data-testid="clinical-document-card__start-date">
                    26 Mar 2015
                   </span>
                   <!--]-->
                  </span>
                  <!--]-->
                 </span>
                </div>
               </td>
               <!--]-->
              </tr>
              <tr class="ant-descriptions-row">
               <!--[-->
               <td class="ant-descriptions-item" colspan="1" style="">
                <div class="ant-descriptions-item-container">
                 <span class="ant-descriptions-item-label" style="width:auto;">
                  <!--[-->
                  <span class="_label_l74zf_1" data-testid="descriptions-item__label--sponsor">
                   Sponsor / Collaborator
                  </span>
                  <!--]-->
                 </span>
                 <span class="ant-descriptions-item-content" style="max-width:100%;">
                  <!--[-->
                  <span class="_content_l74zf_6" data-testid="descriptions-item__value--sponsor">
                   <!--[-->
                   <span style="--bdf8c0bc:14px;">
                    <!--[-->
                    <div class="flex items-center overflow-hidden flex-wrap gap-x-1 gap-y-1">
                     <!--[-->
                     <!--[-->
                     <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _entityTag_3wddt_1" data-testid="entity-tag--organization" style="background:;color:;">
                      <!--[-->
                      <span class="mr-1 h-5 w-5 flex-shrink-0">
                       <!--[-->
                       <span class="_avatar_3wddt_11 ant-avatar ant-avatar-square ant-avatar-image" data-testid="ui-avatar" style="width:20px;height:20px;line-height:20px;font-size:18px;">
                        <img alt="Shire Plc" src="https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod-us/COMPANY/MASTER/LOGO/a586/caf2/b9c5/11e0/df56/bc90/85b1/43c4/1bee424ec35cff8a_48w.webp"/>
                       </span>
                       <!--]-->
                      </span>
                      <a class="flex-1 truncate text-black" href="/organization/a586caf2b9c511e0df56bc9085b143c4" rel="noopener" target="_blank">
                       <!--[-->
                       <!--[-->
                       Shire Plc
                       <!--]-->
                       <!--]-->
                      </a>
                      <!-- -->
                      <!-- -->
                      <!--]-->
                     </span>
                     <!--]-->
                     <!--]-->
                     <!-- -->
                    </div>
                    <!--]-->
                   </span>
                   <!--]-->
                  </span>
                  <!--]-->
                 </span>
                </div>
               </td>
               <!--]-->
              </tr>
              <!--]-->
             </tbody>
            </table>
           </div>
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <!--]-->
   </div>
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <!--[-->
     <span class="_mosaic_dzucl_1">
      <!--[-->
      <span class="font-semibold text-seo-blue-500 underline">
       100
      </span>
      <!--]-->
     </span>
     <!--]-->
     <span>
      Clinical Results associated with rhIGF-1/rhIGFBP-3(Takeda)
     </span>
    </div>
    <div class="inline-flex max-w-full mt-4 w-full">
     <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30 _tipsBorder_b7pjb_9" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
      <!--[-->
      <!--]-->
      <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
       <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
       </path>
      </svg>
      <!--[-->
      <span class="_text_b7pjb_17">
       Login to view more data
      </span>
      <!--]-->
     </div>
    </div>
   </div>
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <!--[-->
     <span class="_mosaic_dzucl_1">
      <!--[-->
      <span class="font-semibold text-seo-blue-500 underline">
       100
      </span>
      <!--]-->
     </span>
     <!--]-->
     <span>
      Translational Medicine associated with rhIGF-1/rhIGFBP-3(Takeda)
     </span>
    </div>
    <div class="inline-flex max-w-full mt-4 w-full">
     <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30 _tipsBorder_b7pjb_9" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
      <!--[-->
      <!--]-->
      <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
       <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
       </path>
      </svg>
      <!--[-->
      <span class="_text_b7pjb_17">
       Login to view more data
      </span>
      <!--]-->
     </div>
    </div>
   </div>
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <!--[-->
     <span class="_mosaic_dzucl_1">
      <!--[-->
      <span class="font-semibold text-seo-blue-500 underline">
       100
      </span>
      <!--]-->
     </span>
     <!--]-->
     <span>
      Patents (Medical) associated with rhIGF-1/rhIGFBP-3(Takeda)
     </span>
    </div>
    <div class="inline-flex max-w-full mt-4 w-full">
     <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30 _tipsBorder_b7pjb_9" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
      <!--[-->
      <!--]-->
      <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
       <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
       </path>
      </svg>
      <!--[-->
      <span class="_text_b7pjb_17">
       Login to view more data
      </span>
      <!--]-->
     </div>
    </div>
   </div>
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <div class="inline-flex max-w-full">
      <!--[-->
      <span class="cursor-pointer font-semibold text-seo-blue-500 underline" data-testid="related-paper-count">
       22
      </span>
      <!--]-->
     </div>
     <span>
      Literatures (Medical) associated with rhIGF-1/rhIGFBP-3(Takeda)
     </span>
    </div>
    <!--[-->
    <div class="_container_8x5ka_1 _literatureCard_nf4fx_1" data-testid="literature-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-col flex-wrap md:flex-row md:items-center md:justify-start">
        <span data-testid="literature-document-card__publication-data">
         01 Jun 2024
        </span>
        <span class="mx-1 hidden md:block">
         ·
        </span>
        <span class="mr-2 text-black" data-testid="literature-document-card__journal-name">
         Pediatric Research
        </span>
        <!-- -->
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_nf4fx_1" data-testid="literature-document-card__title">
              Recombinant IGF-1/BP3 protects against intestinal injury in a neonatal mouse NEC model
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <div class="md:hidden">
          <!-- -->
         </div>
         <div class="hidden md:block">
          <div class="flex">
           <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 mr-2" style="background:#EDF8FF;color:#0170BD;">
            <!--[-->
            Article
            <!--]-->
           </span>
           <!-- -->
          </div>
          <div class="mt-3 line-clamp-3" data-testid="literature-document-card__author">
           Author:
           <!--[-->
           <span>
            Tan, Xiao-Di
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Managlia, Elizabeth
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Barton, Norman
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Carey, Galen
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Yan, Xiaocai
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            De Plaen, Isabelle G
            <!-- -->
           </span>
           <!--]-->
          </div>
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 mt-3" data-testid="literature-document-card__abstract" style="--374e759f:100px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <!--[-->
            <div class="text-text-t2 whitespace-pre-wrap break-words text-sm leading-5">
             <span class="float-left mr-1">
             </span>
             <div class="text-black-default text-sm" style="word-break:break-word;">
              <jats:sec>
               <jats:title>
                BACKGROUND
               </jats:title>
               <jats:p>
                Recombinant human IGF-1/binding protein-3 (rhIGF-1/BP3) is currently being tested in phase II clinical trials in premature infants to prevent bronchopulmonary dysplasia, but its impact on the neonatal intestine remains unclear. The aim of this study was to determine whether rhIGF-1/BP3 protects against necrotizing enterocolitis (NEC) in mice and to investigate the mechanisms involved.
               </jats:p>
              </jats:sec>
              <jats:sec>
               <jats:title>
                METHODS
               </jats:title>
               <jats:p>
                Neonatal mice were dam fed or injected intraperitoneally with rhIGF-1/BP3 (or vehicle) and submitted to an experimental NEC model. Serum IGF-1 was assessed by ELISA and intestinal vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR2) expression by Western blot. Intestinal endothelial cell proliferation, and enterocyte proliferation and migration were examined by immunofluorescence. Pup survival and histological intestinal injury were determined.
               </jats:p>
              </jats:sec>
              <jats:sec>
               <jats:title>
                RESULTS
               </jats:title>
               <jats:p>
                In pups exposed to experimental NEC, serum IBP3-bound IGF-1 level was decreased. Exogenous rhIGF-1/BP3 preserved VEGF and VEGFR2 protein expression, decreased vascular permeability, and preserved endothelial cell proliferation in the small intestine. Furthermore, rhIGF-1/BP3 promoted enterocyte proliferation and migration, which effects were attenuated by inhibiting VEGFR2 signaling, decreased enterocyte apoptosis and decreased systemic and intestinal inflammation. rhIGF-1/BP3 improved survival and reduced the incidence of severe intestinal injury in experimental NEC.
               </jats:p>
              </jats:sec>
              <jats:sec>
               <jats:title>
                CONCLUSIONS
               </jats:title>
               <jats:p>
                Exogenous rhIGF-1/BP3 protects neonatal mice against experimental NEC via multiple mechanisms.
               </jats:p>
              </jats:sec>
              <jats:sec>
               <jats:title>
                IMPACT
               </jats:title>
               <jats:p>
                Exogenous rhIGF-1/BP3 preserves intestinal microvascular development and integrity, promotes enterocyte proliferation and migration, decreases local and systemic inflammation, and protects neonatal mice against NEC. The article adds pre-clinical evidence of a protective role for rhIGF-1/BP3 on the premature gut. It provides evidence supporting the use of rhIGF1/BP3 in premature neonates to protect against NEC.
               </jats:p>
              </jats:sec>
             </div>
            </div>
            <!--]-->
            <!--]-->
           </div>
           <!-- -->
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <div class="_container_8x5ka_1 _literatureCard_nf4fx_1 mt-3" data-testid="literature-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-col flex-wrap md:flex-row md:items-center md:justify-start">
        <span data-testid="literature-document-card__publication-data">
         15 Jun 2023
        </span>
        <span class="mx-1 hidden md:block">
         ·
        </span>
        <span class="mr-2 text-black" data-testid="literature-document-card__journal-name">
         BMC pulmonary medicine
        </span>
        <!-- -->
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_nf4fx_1" data-testid="literature-document-card__title">
              The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism.
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <div class="md:hidden">
          <!-- -->
         </div>
         <div class="hidden md:block">
          <div class="flex">
           <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 mr-2" style="background:#EDF8FF;color:#0170BD;">
            <!--[-->
            Article
            <!--]-->
           </span>
           <!-- -->
          </div>
          <div class="mt-3 line-clamp-3" data-testid="literature-document-card__author">
           Author:
           <!--[-->
           <span>
            Dong, Huaifu
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Zhuo, Feixiang
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Wu, Yumeng
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Chen, Yun
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Shan, Lianqiang
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Chen, Xin
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Wang, Yitong
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Qu, Sehua
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Zhang, Zhen
            <!-- -->
           </span>
           <!--]-->
          </div>
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 mt-3" data-testid="literature-document-card__abstract" style="--374e759f:100px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <!--[-->
            <div class="text-text-t2 whitespace-pre-wrap break-words text-sm leading-5">
             <span class="float-left mr-1">
             </span>
             <div class="text-black-default text-sm" style="word-break:break-word;">
              <jats:sec>
               <jats:title>
                BACKGROUND
               </jats:title>
               <jats:p>
                This study aimed to determine whether postnatal treatment with recombinant human IGF-1 (rhIGF-1)/binding peptide 3 (BP3) ameliorates lung injury and prevents pulmonary hypertension (PH) in bronchopulmonary dysplasia (BPD) models.
               </jats:p>
              </jats:sec>
              <jats:sec>
               <jats:title>
                METHODS
               </jats:title>
               <jats:p>
                We used two models of BPD in this study: one model that was associated with chorioamnionitis (CA), stimulated by intra-amniotic fluid and exposure to lipopolysaccharide (LPS), whereas the other was exposed to postnatal hyperoxia. Newborn rats were treated with rhIGF-1/BP3 (0.2 mg/Kg/d) or saline via intraperitoneal injection. The study endpoints included the wet/dry weight (W/D) ratio of lung tissues, radial alveolar counts (RACs), vessel density, right ventricular hypertrophy (RVH), lung resistance, and lung compliance. Hematoxylin and eosin (H&amp;E) and Masson staining were used to evaluate the degree of lung injury and pulmonary fibrosis. IGF-1 and eNOS expression were detected using western blotting or quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). The levels of SP-C, E-cadherin, N-cadherin, FSP1, and Vimentin in the lung tissues were detected by immunofluorescence.
               </jats:p>
              </jats:sec>
              <jats:sec>
               <jats:title>
                RESULTS
               </jats:title>
               <jats:p>
                LPS and hyperoxia treatment increased lung injury and pulmonary fibrosis, enhanced RVH and total respiratory resistance, and decreased RAC, pulmonary vascular density and pulmonary compliance in young mice (all p &lt; 0.01). Simultaneously, LPS and hyperoxia induced an increase in epithelial-mesenchymal transition (EMT) in airway epithelial cells. However, rhIGF-1/BP3 treatment reduced lung injury and pulmonary fibrosis, decreased RVH and total respiratory resistance, and enhanced RAC, pulmonary vascular density and pulmonary compliance, as well as inhibited EMT in airway epithelial cells in LPS and hyperoxia treated mice.
               </jats:p>
              </jats:sec>
              <jats:sec>
               <jats:title>
                CONCLUSION
               </jats:title>
               <jats:p>
                Postnatal rhIGF-1/BP3 treatment relieved the effects of LPS or hyperoxia on lung injury and prevented RVH, providing a promising strategy for the treatment of BPD.
               </jats:p>
              </jats:sec>
             </div>
            </div>
            <!--]-->
            <!--]-->
           </div>
           <!-- -->
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <div class="_container_8x5ka_1 _literatureCard_nf4fx_1 mt-3" data-testid="literature-document-card">
     <!-- -->
     <!--[-->
     <div class="_container_afoc1_1 border">
      <div class="_subTitle_afoc1_14">
       <!--[-->
       <div class="flex flex-col flex-wrap md:flex-row md:items-center md:justify-start">
        <span data-testid="literature-document-card__publication-data">
         01 May 2022
        </span>
        <span class="mx-1 hidden md:block">
         ·
        </span>
        <span class="mr-2 text-black" data-testid="literature-document-card__journal-name">
         Journal of Pharmaceutical Sciences
        </span>
        <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _quartileTag_x54hj_1 _quartile_nf4fx_11" data-testid="literature-quartile" style="background:;color:;">
         <!--[-->
         Q3
         <span class="mx-0.5">
          ·
         </span>
         MEDICINE
         <!--]-->
        </span>
       </div>
       <!--]-->
      </div>
      <div class="mt-2 flex items-start">
       <div class="flex-1 overflow-hidden">
        <div class="flex">
         <div>
          <div class="_title_afoc1_6">
           <!--[-->
           <div class="inline-flex max-w-full">
            <div class="_tipsContainer_b7pjb_1 _normal_b7pjb_23" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
             <!--[-->
             <!--]-->
             <!-- -->
             <!--[-->
             <!--[-->
             <span class="_title_nf4fx_1" data-testid="literature-document-card__title">
              Development of Protein-Specific Analytical Methodologies to Evaluate Compatibility of Recombinant Human (rh)IGF-1/rhIGFBP-3 with Intravenous Medications Co-Administered to Neonates
             </span>
             <!--]-->
             <!--]-->
            </div>
           </div>
           <!--]-->
          </div>
          <!--[-->
          <!--]-->
         </div>
         <!-- -->
        </div>
        <div class="_content_afoc1_31">
         <!--[-->
         <div class="md:hidden">
          <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 _quartileTag_x54hj_1" data-testid="literature-quartile" style="background:;color:;">
           <!--[-->
           Q3
           <span class="mx-0.5">
            ·
           </span>
           MEDICINE
           <!--]-->
          </span>
         </div>
         <div class="hidden md:block">
          <div class="flex">
           <span class="_tag_5lm5p_1 _default_5lm5p_20 _small_5lm5p_31 mr-2" style="background:#EDF8FF;color:#0170BD;">
            <!--[-->
            Article
            <!--]-->
           </span>
           <!-- -->
          </div>
          <div class="mt-3 line-clamp-3" data-testid="literature-document-card__author">
           Author:
           <!--[-->
           <span>
            Turner, Mark
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            McPherson, Christopher
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Salamat-Miller, Nazila
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Salinas, Paul A
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Barton, Norman
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Chadwick, Jennifer S
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Wang, Dongdong
            <span class="mr-1">
             ;
            </span>
           </span>
           <span>
            Qu, Wanlu
            <!-- -->
           </span>
           <!--]-->
          </div>
          <div class="_container_16a6u_1 _containerStyle_16a6u_7 mt-3" data-testid="literature-document-card__abstract" style="--374e759f:100px;--661d8904:#1976d2;--470d35e6:20px;--78a7937a:20px;--cab18e14:#1976d2;--324c64a8:#1976d2;--8277a0b4:0px;">
           <div>
            <!--[-->
            <!--[-->
            <div class="text-text-t2 whitespace-pre-wrap break-words text-sm leading-5">
             <span class="float-left mr-1">
             </span>
             <div class="text-black-default text-sm" style="word-break:break-word;">
              <jats:sec>
               <jats:p>
                The protein complex of recombinant human insulin-like growth factor-1 and insulin‑like growth factor binding protein‑3 (rhIGF-1/rhIGFBP-3; mecasermin rinfabate), is an investigational product for the prevention of complications of prematurity. Delivery of rhIGF-1/rhIGFBP-3 is by continuous central line intravenous infusion in preterm infants until endogenous IGF-1 production begins. Protein-specific analytical methodologies were developed to evaluate the compatibility of rhIGF-1/rhIGFBP-3 at low protein concentrations (∼2.5-10 μg/mL) expected when co-administered with other required medications in the NICU. Highly sensitive detection of the biologic potential degradants (fragments) and/or molecular modifications (oxidized species, aggregates) required the use of reversed-phase high-performance liquid chromatography and size-exclusion ultra-performance liquid chromatography coupled with mass spectrometric detection. We report on the quantification of rhIGF-1/rhIGFBP-3, its components and degradants, to a limit of quantitation of 3.1 μg/mL upon mixing with 24 commonly administered neonatal medications. Methods developed for the rhIGF-1/rhIGFBP-3 admixtures, optimized in studies with furosemide, caffeine citrate and ampicillin, demonstrated good reproducibility, linearity, and limit of detection/quantitation. Using these methods, no increase in degradation of rhIGF-1/rhIGFBP-3 components and no increase in oxidation or aggregation level was observed with caffeine citrate, while admixtures of rhIGF-1/rhIGFBP-3 with ampicillin yielded lower mass recovery of rhIGF-1/rhIGFBP-3 components, which likely resulted from adduct formation. Furosemide was found to be physically incompatible with rhIGF-1/rhIGFBP-3. Our findings support the use of these methodologies for detection of protein modifications under various clinical administration conditions, and additionally supplement physical compatibility data studies of ultra-low concentrations of rhIGF-1/rhIGFBP-3 post co-administration to preterm infants with other medications (manuscript in-preparation).
               </jats:p>
              </jats:sec>
             </div>
            </div>
            <!--]-->
            <!--]-->
           </div>
           <!-- -->
          </div>
         </div>
         <!--]-->
        </div>
       </div>
      </div>
     </div>
     <!--]-->
    </div>
    <!--]-->
   </div>
   <!-- -->
   <div class="mt-10 md:mt-12">
    <div class="mb-4 break-all text-sm text-black">
     <!--[-->
     <span class="_mosaic_dzucl_1">
      <!--[-->
      <span class="font-semibold text-seo-blue-500 underline">
       100
      </span>
      <!--]-->
     </span>
     <!--]-->
     <span>
      Deals associated with rhIGF-1/rhIGFBP-3(Takeda)
     </span>
    </div>
    <div class="inline-flex max-w-full mt-4 w-full">
     <div class="_tipsContainer_b7pjb_1 _yellow_b7pjb_30 _tipsBorder_b7pjb_9" dialogtype="common" entrancetype="text" isallinforegister="false" showjumptip="true" size="medium" style="--28c9148e:4px;" type="default">
      <!--[-->
      <!--]-->
      <svg class="h-4 w-[10px]" fill="currentColor" height="1.2em" viewbox="0 0 10 16" width="1.2em">
       <path d="M9.70678 6.27142H5.92999L6.67408 0.15021C6.68107 0.0907286 6.65118 0.0334335 6.60111 0.0103023C6.55104 -0.0128288 6.49315 0.00392205 6.45976 0.0512057L0.0610803 9.20641C-0.00721034 9.30424 -0.0192403 9.43647 0.0300607 9.54737C0.0793617 9.65827 0.181418 9.72854 0.293217 9.72858H4.07001L3.32592 15.8498C3.31893 15.9093 3.34882 15.9666 3.39889 15.9897C3.44896 16.0128 3.50685 15.9961 3.54024 15.9488L9.93892 6.79359C10.0072 6.69576 10.0192 6.56353 9.96994 6.45263C9.92064 6.34174 9.81858 6.27146 9.70678 6.27142Z" fill-rule="evenodd">
       </path>
      </svg>
      <!--[-->
      <span class="_text_b7pjb_17">
       Login to view more data
      </span>
      <!--]-->
     </div>
    </div>
   </div>
   <!--]-->
  </div>
 </div>
</div>
